Stemedica Cell Technologies announced positive results from its Phase I/IIa clinical study for the treatment of ischemic...
Eli Lilly and Loxo Oncology, have announced a definitive agreement for Lilly to acquire Loxo Oncol...
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced Project ALPHA (Analytics fo...
Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...
Green Leaf Medical, LLC, a MSO (Multi-State Operator) of medical cannabis facilities in the Northeast United S...
The University of Texas MD Anderson Cancer Centre and 4D pharma has announced a strategic collaboration to evaluate...
Ironwood Pharmaceuticals, Inc. has announced that Michael Shetzline, M.D., Ph.D., will join Ironwood as chief medical of...
Bristol-Myers Squibb Company and Celgene Corporation has announced that they have entered into a definitive merger agree...
Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...
Generex Biotechnology Corporation has announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeu...
AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...
ImaginAb, a clinical stage immuno-oncology imaging company has announced the appointment of Friedhelm Blobel, Ph.D...
Correvio Pharma Corp, a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs h...
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...
The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...
AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...
Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to pr...
Alexion Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS&trad...
